Insight on submission of USFDA sBLA of Tremfya (guselkumab) for the treatment of adult patients with active psoriatic arthritis (PsA)
Posted on18 Sep 2019
TagsJanssen, Janssen Biotech, Janssen Pharma, MorphoSys AG, sBLA, supplemental Biologics License Application, Tremfya
Comments0
MorphoSys AG, a clinical-stage biopharmaceutical company, announced that its licensee Janssen Research & Development, submitted a supplemental Biologics License Application (sBLA) to... Read More
PREZCOBIX™ (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1
Posted on30 Jan 2015
Tagsfixed-dose antiretroviral combination tablet, J&J, Janssen, Janssen Pharma, once-daily, PREZCOBIX
Comments0
Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced the U.S. Food and Drug Administration (FDA) has approved PREZCOBIX™ (darunavir 800... Read More
Depomed buys suite of Janssen pain drugs for $1bn
Posted on19 Jan 2015
Comments0
Tapentadol is a centrally acting analgesic with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine... Read More